Generalization of the homogeneity index for multi-target radiotherapy plans


Abstract

Background and Purpose: Considering the inaccuracies of current homogeneity index (HI) formulas in multi-target plans, we have redefined the V PTV in the formula for calculating the HI value of target volumes in multi-target plans, providing a reference for clinical applications.

Methods and Materials: Given the inaccuracies of the three widely used HI formulas in evaluating multi-target treatment plans, we have redefined the V PTV calculation formula to ensure that the computed HI values more accurately reflect the dose homogeneity within the target volumes. Fifteen clinically treated breast cancer (BC) patients with conserving surgery patients and fifteen nasopharyngeal carcinoma (NPC) patients were chosen. Using our proposed formula, we calculated the VPTV with the name of VPTVpro and the HIpro1 , HIpro2 , and HIpro3 . A paired, two-tailed non-parametric Wilcoxon signed-rank test was utilized to compare VPTV ori and VPTVpro , HIori1 and HIpro1 , HIori2 and HIpro2 , HIori3 and HIpro3 . The correlations between HI ori1 and HIpro1, HIori2 and HIpro2, and HIori3 and HIpro3 were also analyzed, and Pearson’s correlation coefficients were calculated.

Results: For PTV of BC and PTV1 of NPC, the VPTVpro values calculated using our proposed method were significantly smaller than the original VPTVori values. The HI values calculated from the three formulas, as well as the HIori and HIpro values, showed statistically significant differences, with HIpro being significantly lower than HIori. For PTV of BC and PTV1 of NPC, the correlation coefficient values between HIori1 -HIpro1, HIori2 -HIpro2, and HIori3 -HIpro3 showed variations, though all demonstrated positive correlations with statistically significant p-values <0.01. The computational results for these two target volumes revealed a consistent pattern: the HIori1-HIpro1 pair exhibited the highest correlation coefficient values, while HIori2-HIpro2 consistently showed the lowest values among the three method comparisons.

Conclusions: The new VPTV subtracts the high-dose target volume within the low-dose target volume, making it more reasonable and accurate than previous formulas in reflecting the HI value of the analyzed low-dose target volume. Additionally, the new VPTV proposed in this paper is also applicable for HI calculation in a single-target volume. We suggest using the new VPTV proposed in this study to calculate the HI value of the target area for multi-target plans, such as BC with conserving surgery and NPC. Meanwhile, we recommend employing Formula 1 for the calculation of the target HI among the three formulas.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.

  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].